The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28−CD8+ T Cells
Abstract
A substantial proportion of CD8+ T cells in adults lack the expression of the CD28 molecule, and the aging of the immune system is associated with a steady expansion of this T cell subset. CD28−CD8+ T cells are characterized by potent effector functions but impaired responses to antigenic challenge. CD28 acts as the primary T cell costimulatory receptor, but there are numerous additional receptors that can costimulate the activation of T cells. In this study, we have examined such alternative costimulatory pathways regarding their functional role in CD28−CD8+ T cells. Our study showed that most costimulatory molecules have a low capacity to activate CD28-deficient T cells, whereas the engagement of the CD2 molecule by its ligand CD58 clearly costimulated proliferation, cytokine production, and effector function in this T cell subset. CD58 is broadly expressed on APCs including dendritic cells. Blocking CD58 mAb greatly reduced the response of human CD28−CD8+ T cells to allogeneic dendritic cells, as well as to viral Ags. Our results clearly identify the CD58/CD2 axis as the primary costimulatory pathway for CD8 T cells that lack CD28. Moreover, we show that engagement of CD2 amplifies TCR signals in CD28−CD8+ T cells, demonstrating that the CD2–CD58 interaction has a genuine costimulatory effect on this T cell subset. CD2 signals might promote the control of viral infection by CD28−CD8+ T cells, but they might also contribute to the continuous expansion of CD28−CD8+ T cells during chronic stimulation by persistent Ag.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, the CD58/CD2 axis is a potent co-stimulatory pathway in CD8+ T cells that lack expression of CD28 (CD8+CD28- T cells)29, which are common in the tumor-microenvironment and peripheral blood of solid tumor patients30, and were the predominant T cells in our Perturb-CITE-Seq screen”
From Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion (2021) · cites this paper as [29]
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Sharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571
Phenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366
TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Meuer, S. C., Hussey, R. E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K. A., Hodgdon, J. C., Protentis, J. P., Schlossman, S. F., & Reinherz, E. L. (1984) · Cell · doi:10.1016/0092-8674(84)90039-4 · Cited by 1,113
Cited by
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
Transcriptomic analysis of purified human cortical microglia reveals age-associated changes
Galatro, T. F., Holtman, I. R., Lerario, A. M., Vainchtein, I. D., Brouwer, N., Sola, P. R., Veras, M. M., Pereira, T. F., Leite, R. E. P., Möller, T., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4597 · Cited by 741
Wauters, E., Van Mol, P., Garg, A. D., Jansen, S., Van Herck, Y., Vanderbeke, L., Bassez, A., Boeckx, B., Malengier-Devlies, B., Timmerman, A., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00455-9 · Cited by 345
Frangieh, C. J., Melms, J. C., Thakore, P. I., Geiger-Schuller, K. R., Ho, P., Luoma, A. M., Cleary, B., Jerby-Arnon, L., Malu, S., Cuoco, M. S., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00779-1 · Cited by 276
Wosen, J. E., Mukhopadhyay, D., Macaubas, C., & Mellins, E. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02144 · Cited by 237
Jutz, S., Leitner, J., Schmetterer, K., Doel-Perez, I., Majdic, O., Grabmeier-Pfistershammer, K., Paster, W., Huppa, J. B., & Steinberger, P. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.01.007 · Cited by 207
Self-citationBinder, C., Cvetkovski, F., Sellberg, F., Berg, S., Visbal, H. P., Sachs, D. H., Berglund, E., & Berglund, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01090 · Cited by 172
CD11c+ B Cells Are Mainly Memory Cells, Precursors of Antibody Secreting Cells in Healthy Donors
Golinski, M.-L., Demeules, M., Derambure, C., Riou, G., Maho‐Vaillant, M., Boyer, O., Joly, P., & Calbo, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00032 · Cited by 147
Demetriou, P., Abu‐Shah, E., Valvo, S., McCuaig, S., Mayya, V., Kvalvaag, A. S., Starkey, T., Korobchevskaya, K., Lee, L. Y. W., Friedrich, M., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0770-x · Cited by 136
Nicolai, C. J., Parker, M. H., Qin, J., Tang, W., Ulrich-Lewis, J. T., Gottschalk, R., Cooper, S. E., Lopez, S. A. H., Parrilla, D., Mangio, R. S., et al. (2024) · Blood · doi:10.1182/blood.2024024523 · Cited by 148
Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants
Marciani, D. J. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.03.005 · Cited by 127
Born to survive: how cancer cells resist CAR T cell therapy
Lemoine, J., Ruella, M., & Houot, R. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01209-9 · Cited by 142
The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin
Magatti, M., Vertua, E., Cargnoni, A., Silini, A. R., & Parolini, O. (2018) · Cell Transplantation · doi:10.1177/0963689717742819 · Cited by 124
Gao, Y., Yao, X., Zhai, Y., Li, L., Li, H., Sun, X., Yu, P., Xue, T., Li, Y., & Hu, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03724-6 · Cited by 113
Rosa, B. A., Ahmed, M., Singh, D. K., Choreño-Parra, J. A., Cole, J., Jiménez-Álvarez, L. A., Rodríguez-Reyna, T. S., Singh, B., Gonzalez, O., Carrion, R., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01829-4 · Cited by 106
Rosskopf, S., Leitner, J. M., Paster, W., Morton, L. T., Hagedoorn, R. S., Steinberger, P., & Heemskerk, M. H. M. (2018) · Oncotarget · doi:10.18632/oncotarget.24807 · Cited by 99
Self-citationThe CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
Ho, P., Melms, J. C., Rogava, M., Frangieh, C. J., Poźniak, J., Shah, S. B., Walsh, Z. H., Kyrysyuk, O., Amin, A. D., Caprio, L., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.05.014 · Cited by 118
CD58 Immunobiology at a Glance
Zhang, Y., Liu, Q., Yang, S., & Liao, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705260 · Cited by 94
Stecher, C., Battin, C., Leitner, J. M., Zettl, M., Grabmeier‐Pfistershammer, K., Höeller, C., Zlabinger, G. J., & Steinberger, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00572 · Cited by 77
Self-citationSuppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses
Wang, E. C. Y., Pjechová, M., Nightingale, K., Vlahava, V.-M., Patel, M., Růčková, E., Forbes, S. K., Nobre, L., Antrobus, R., Roberts, D. L., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720950115 · Cited by 73
CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
Huang, J., Huang, X., & Huang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1019115 · Cited by 77
Burton, J., Siller‐Farfán, J. A., Pettmann, J., Salzer, B., Kutuzov, M. A., van der Merwe, P. A., & Dushek, O. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216352120 · Cited by 66
Huo, X., Dai, Y., Yang, T., Zhang, Y., Li, M., & Xu, X. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.02.040 · Cited by 62
Signals Controlling Lytic Granule Polarization at the Cytotoxic Immune Synapse
Kabanova, A., Zurli, V., & Baldari, C. T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00307 · Cited by 68
HCMV-Encoded NK Modulators: Lessons From in vitro and in vivo Genetic Variation
Patel, M., Vlahava, V.-M., Forbes, S. K., Fielding, C. A., Stanton, R. J., & Wang, E. C. Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02214 · Cited by 56
Orlik, C., Deibel, D., Küblbeck, J., Balta, E., Ganskih, S., Habicht, J. L., Niesler, B., Schröder–Braunstein, J., Schäkel, K., Wabnitz, G. H., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0261-x · Cited by 62
Yang, Z., Hou, Y., Grande, G., Cho, J. H., Wang, C., Shi, Y., Žák, J., Wan, Y., Qin, K., Liu, D., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01202-w · Cited by 53
Wen, L., Zhu, C., Zhu, Z., Yang, C., Zheng, X., Liu, L., Zuo, X., Sheng, Y., Tang, H., Liang, B., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211823 · Cited by 50
Tuning the Orchestra: HCMV vs. Innate Immunity
Dell’Oste, V., Biolatti, M., Galitska, G., Griffante, G., Gugliesi, F., Pasquero, S., Zingoni, A., Cerboni, C., & Andrea, M. D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00661 · Cited by 51
Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging
Michel, J. J., Griffin, P. C., & Vallejo, A. N. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00530 · Cited by 45
Shen, Y., Eng, J. S., Fajardo, F., Liang, L., Li, C., Collins, P. J., Tedesco, D., & Nolan-Stevaux, O. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004348 · Cited by 41
Toward precision manufacturing of immunogene T-cell therapies
Xu, J., Melenhorst, J. J., & Fraietta, J. A. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2017.12.007 · Cited by 38
van Aalderen, M. C., van den Biggelaar, M., Remmerswaal, E. B. M., van Alphen, F. P. J., Meijer, A. B., ten Berge, I. J. M., & van Lier, R. A. W. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.014 · Cited by 44
Costimulatory Function of Cd58/Cd2 Interaction in Adaptive Humoral Immunity in a Zebrafish Model
Shao, T., Shi, W. M., Zheng, J.-Y., Xu, X., Lin, A., Xiang, L., & Shao, J.-Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01204 · Cited by 35
Chen, B., Morris, S. R., Panigrahi, S., Michaelson, G. M., Wyrick, J. M., Komissarov, A. A., Potashnikova, D. M., Lebedeva, А., Younes, S., Harth, K. C., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900734 · Cited by 40
CMV Status Drives Distinct Trajectories of CD4+ T Cell Differentiation
Zhang, W., Morris, A. B., Peek, E. V., Karadkhele, G. M., Robertson, J. M., Kissick, H. T., & Larsen, C. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.620386 · Cited by 34
Clinical consequences of circulating CD28-negative T cells for solid organ transplantation
Betjes, M. G. H. (2015) · Transplant International · doi:10.1111/tri.12658 · Cited by 35
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
Jo, Y., Sim, H.-I., Yun, B., Park, Y., & Jin, H. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01317-9 · Cited by 36
Kim, M., Lee, S., Shin, S., Park, K., Park, S., & Lee, C. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-29048-8 · Cited by 30
Zurli, V., Montecchi, T., Heilig, R., Poschke, I. C., Volkmar, M., Wimmer, G., Boncompagni, G., Turacchio, G., D’Elios, M. M., Campoccia, G., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz1965 · Cited by 36
Human CD8+ T Cells Exhibit a Shared Antigen Threshold for Different Effector Responses
Abu‐Shah, E., Trendel, N., Krüger, P., Nguyen, J., Pettmann, J., Kutuzov, M. A., & Dushek, O. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000525 · Cited by 29
IFNγ, and to a Lesser Extent TNFα, Provokes a Sustained Endothelial Costimulatory Phenotype
Valenzuela, N. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.648946 · Cited by 32
Gao, Y., Li, H., Li, Z., Xie, L., Liu, X., Huang, Z., Chen, B., Lin, X., Wang, X., Zheng, Y., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100094 · Cited by 24
Rapid Generation of Therapeutic Nanoparticles Using Cell‐Free Expression Systems
Peruzzi, J. A., Vu, T. Q., Gunnels, T. F., & Kamat, N. P. (2023) · Small Methods · doi:10.1002/smtd.202201718 · Cited by 20
Extrinsic and intrinsic drivers of natural killer cell clonality
Rückert, T., & Romagnani, C. (2024) · Immunological Reviews · doi:10.1111/imr.13324 · Cited by 22
Pinheiro‐de‐Sousa, I., Fonseca‐Alaniz, M. H., Teixeira, S. K., Rodrigues, M. V., & Krieger, J. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-05404-7 · Cited by 23
Chimeric non-antigen receptors in T cell-based cancer therapy
Guo, J., Kent, A., & Dávila, E. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002628 · Cited by 17
Schlenker, R., Schwalie, P. C., Dettling, S., Huesser, T., Irmisch, A., Mariani, M., Gómez, J. M. M., Ribeiro, A., Limani, F., Herter, S., et al. (2024) · Med · doi:10.1016/j.medj.2024.03.015 · Cited by 21
Younes, S. F., Zhao, S., Bharadwaj, S., Mosquera, A. P., Libert, D. M., Johnsrud, A. J., Majzner, R. G., Miklos, D. B., Frank, M. J., & Natkunam, Y. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100256 · Cited by 16
Association of CD58 gene polymorphisms with NMO spectrum disorders in a Han Chinese population
Liu, J., Shi, Z., Lian, Z., Chen, H., Zhang, Q., Feng, H., Miao, X., Du, Q., & Zhou, H. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.05.003 · Cited by 15
Zhang, Y., LeWitt, T. M., Louissaint, A., Guitart, J., Zhou, X. A., & Choi, J. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.07.027 · Cited by 15
Khan, Z., Mehan, S., Maurya, P. K., Kumar, A., Gupta, G. D., Narula, A. S., & Kalfin, R. E. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303325979241206115417 · Cited by 15
Tang, J. J.-J., Sung, A. P., Guglielmo, M. J., Navarrete-Galvan, L. T., Redelman, D. D., Smith‐Gagen, J., & Hudig, D. (2020) · Antibodies · doi:10.3390/antib9040054 · Cited by 12
Demetriou, P., Abu‐Shah, E., McCuaig, S., Mayya, V., Valvo, S., Korobchevskaya, K., Friedrich, M., Mann, E. H., Lee, L. Y. W., Starkey, T., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/589440 · Cited by 12
Chen, C., Chen, Z., Chio, C. L., Zhao, Y., Li, Y., Liu, Z., Jin, Z., Wu, X., Wei, W., Zhao, Q., et al. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211052152 · Cited by 10
The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunityPreprint
Ho, P., Melms, J. C., Rogava, M., Frangieh, C. J., Shah, S. B., Walsh, Z. H., Kyrysyuk, O., Amin, A. D., Caprio, L., Fullerton, B. T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.21.485049 · Cited by 10
Discordant CAR-T cell signaling: implications of divergence from physiological T cell activation
Gonzalez‐Garcia, P., Moares, N., Serrano-García, I., Fernández-Cisnal, R., Luna‐Espejo, R., Ocaña‐Cuesta, J., Yi‐He, W., Muñoz-Miranda, J. P., Gabucio, A., Fernandez-Ponce, C. M., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06857-w · Cited by 10
Sergeeva, O. A., Jin, G., Sarkar, M., Zeiger, J., Dhindwal, S., Chin, S. S., Abulizi, A., Lai, Z., Brown, C., DeMaria, W. G., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2510829122 · Cited by 9
Mężyk-Kopeć, R., Potin, L., Medellin, J. E. G., Salles, C. M., & Swartz, M. A. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200216 · Cited by 8
Neutrophils promote T-cell–mediated inflammation in allergy
Polak, D., Samadi, N., Vizzardelli, C., Acosta, G. S., Rosskopf, S., Steinberger, P., Jahn‐Schmid, B., & Bohle, B. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.035 · Cited by 8
Self-citationGarcía‐Torre, A., Bueno‐García, E., Moro‐García, M. A., López‐Martínez, R., Rioseras, B., Molina, B. D., Lambert, J. L., & Alonso‐Arias, R. (2024) · Immunology · doi:10.1111/imm.13824 · Cited by 7
Pemmari, A., Leppänen, T., Paukkeri, E., Eskelinen, A. P., Moilanen, T. P. S., & Moilanen, E. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.03.014 · Cited by 7
Liu, X., Yue, Z., Cao, Y., Taylor, L., Zhang, Q., Choi, S. W., Hanash, S., Ito, S., Chen, J. Y., Wu, H., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00365 · Cited by 6
Mutational landscape of immune surveillance genes in diffuse large B-cell lymphoma
Nesic, M., El‐Galaly, T. C., Bøgsted, M., Pedersen, I. S., & Dybkær, K. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1755958 · Cited by 7
Hitomi, Y., Ueno, K., Aiba, Y., Nishida, N., Kawai, Y., Kawashima, M., Khor, S., Takada, S., Iwabuchi, C., Nagasaki, M., et al. (2023) · Human Genetics · doi:10.1007/s00439-023-02617-2 · Cited by 6
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
Carturan, A., Angelos, M. G., Guruprasad, P., Patel, R. P., Pajarillo, R., Lee, A. E., Zhang, Y., Zhang, Y., Xie, W., Rodriguez, J. L., et al. (2026) · Blood · doi:10.1182/blood.2025031409 · Cited by 6
The power of human cytomegalovirus (HCMV) hijacked UL/b' functions lost in vitro
Kempová, V., Lenhartová, S., Benko, M., Nemčovič, M., Kúdelová, M., & Nemčovičová, I. (2020) · Acta Virologica · doi:10.4149/av_2020_202 · Cited by 5
Transplantation tolerance after allograft rejection
Miller, M. L., Alegre, M., & Chong, A. S. (2016) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000374 · Cited by 5
Pan, D., Das, A., Srivastav, S., Traina‐Dorge, V., Didier, P. J., & Pahar, B. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001181 · Cited by 5
The Pathogenic Role of Expanded CD8⁺CD28null Angiogenic T Cells in ANCA-Associated Vasculitis
Shen, H., Miao, J., Sun, H., Zhang, K., Liu, R., Li, Z., Zhang, L., Zhang, P., Wang, J., Zhang, B., et al. (2024) · Biomedicines · doi:10.3390/biomedicines13010026 · Cited by 5
How crosstalk at the immune synapse shapes T cell and dendritic cell biology
Martin-Cofreces, N. B., Calzada‐Fraile, D., & Sánchez‐Madrid, F. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-025-01262-2 · Cited by 11
Yu, Y., Lien, W., Lin, W., Pan, Y., Huang, S., Mou, C., Hu, C. J., & Mou, Y. (2024) · Advanced Science · doi:10.1002/advs.202310204 · Cited by 3
Sun, Z., Lin, J., Sun, X., Yun, Z., Zhang, X., Xu, S., Duan, J., & Yao, K. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41641 · Cited by 4
Mechanisms and implications of vascular-homing CD8 T cells in atherosclerosis
Su, X., O’Hare, K. A., & Freeman, M. L. (2025) · npj Cardiovascular Health · doi:10.1038/s44325-025-00056-8 · Cited by 6
Liu, C., Wu, H., Li, K., Chi, Y., Wu, Z., & Xing, C. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18398 · Cited by 4
Zhang, Y., Zheng, H., Zhang, R., Li, J., Yang, S., Hua, Y., Kleeff, J. H., Liao, Q., & Liu, Q. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012163 · Cited by 6
A potential prognostic marker for hematologic neoplasms: CD58
Cao, J., Zhang, Y., Yue, N., Xiong, S., Zhang, S., & Wu, C. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1586842 · Cited by 3
Gómez-Henao, W., Saavedra, R., Chávez, R., Lascuraín, R., Zenteno, E., & Tenorio, E. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.788880 · Cited by 3
Transcriptional reprogramming via signaling domains of CD2, CD28, and 4-1BB
Linhares, A. D. S., Sharma, S., Steinberger, P., & Leitner, J. M. (2024) · iScience · doi:10.1016/j.isci.2024.109267 · Cited by 4
Self-citationZheng, H., Chen, Y., Li, J., Zhang, Y., Li, H., Zhao, X., He, Z., Liao, Y., Zhang, Z., Shi, H., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.05.031 · Cited by 2
Sk, O. F., Hazra, I., Datta, A., Mondal, S., Moitra, S., Chaudhuri, S., Das, P. K., Basu, A. K., Mishra, R., & Chaudhuri, S. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.04.021 · Cited by 4
Enhancing the anti-tumor efficacy of Bispecific T cell engagers via cell surface glycocalyx editingPreprint
Yang, Z., Hou, Y., Grande, G., Wang, C., Shi, Y., Žák, J., Cho, J. H., Liu, D., Teijaro, J. R., Lerner, R. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.22.492978 · Cited by 3
Diversity of CD28null T Cells in the Elderly: A Glimpse in a Biological Adaptation of Aging
Griffin, P. C., Michel, J. J., & Vallejo, A. N. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_87-1 · Cited by 2
Burton, J., Siller‐Farfán, J. A., André, V., Jenkins, E. M., Barton, M. I., Eguiguren, S. B., Cabezas-Caballero, J., Davis, S. J., Weikl, T. R., van der Merwe, P. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.06.631424 · Cited by 5
Xu, X., Li, Y., Liang, Y., Yin, M., Zhang, Y., Huang, L., Yu, Z., & Ni, J. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.06.010 · Cited by 1
Diversity of CD28null T Cells in the Elderly: A Glimpse in a Biological Adaptation of Aging
Griffin, P. C., Michel, J. J., & Vallejo, A. N. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_87 · Cited by 1
Voda, A.-I., Correa, K., Hamp, J., Moscrop, C., Dustin, M. L., & Jostins-Dean, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.23.517727 · Cited by 1
Maecker, H. T. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.740049948.793585672
Generation and Gene Expression of CD28−CD8 T Cells in Human
Kim, J., & Weng, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_17
Generation and Gene Expression of CD28−CD8 T Cells in Human
Kim, J., & Weng, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_17-1
Faculty Opinions recommendation of CD28 costimulation: from mechanism to therapy.
Tuosto, L. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726363559.793546230
Voda, A.-I., Correa, K., Hamp, J., Moscrop, C., Dustin, M. L., & Jostins-Dean, L. (2023) · doi:10.7554/elife.86891.1
Voda, A.-I., Correa, K., Hamp, J., Moscrop, C., Dustin, M. L., & Jostins-Dean, L. (2023) · doi:10.7554/elife.86891
PD-L1 and CD58 co-regulated by CMTM6 play yin and yang to shape anti-tumor immunity
Yamaguchi, H., & Hung, M. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.08.009 · Cited by 1
Control of CD58 by NOD2.Preprint
Mamoor, S. (2023) · doi:10.31219/osf.io/m5dzt
Ji, Y., Xia, P., Wang, Y., Liu, Y., Wang, F., Sun, F., Feng, Q., Ni, Q., & Li, Y. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1554139
Chen, J., Peng, L., Yang, T., Chen, S., Tang, Y., Li, D., & Yuan, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07840-9 · Cited by 1
Genetic‐Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis
Ding, Y., Hamitouche, D., Thebault, S., Kearns, P., Abdelhak, A., & Harroud, A. (2026) · Annals of Neurology · doi:10.1002/ana.78256
Metadata
- Authors
- Leitner, J., Herndler-Brandstetter, D., Zlabinger, G. J., Grubeck-Loebenstein, B., & Steinberger, P.
- Affiliations
- Medical University of Vienna (AT)
- Institute for Biomedical Aging Research, University of Innsbruck , 6020 Innsbruck ,
- Corresponding author
- Leitner, Judith
- Steinberger, Peter
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-07
- Volume
- 195
- Issue
- 2
- Pages
- 477-487
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1953155836
- Cited by
- 104
- References
- 57
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 13 · 2020: 11 · 2019: 7 · 2018: 16 · 2017: 7 · 2016: 4 · 2015: 1
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research Institute
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- T cell costimulation, CD2, CD58, T cell activation, dendritic cells, allogeneic response, T cell proliferation, cytokine production, effector function, T cell senescence, chronic antigenic stimulation
- MeSH terms
- Aged, Amino Acid Sequence, Antigens, Viral, Dendritic Cells, Gene Expression Regulation, Humans, Lymphocyte Activation, Molecular Sequence Data, Orthomyxoviridae, Peptides, Signal Transduction, CD4-Positive T-Lymphocytes, Immunophenotyping, T-Lymphocyte Subsets, CD8 Antigens, CD28 Antigens, CD8-Positive T-Lymphocytes, CD2 Antigens, CD58 Antigens, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.